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Abstract 
Cognitive neuroscience research has traditionally overlooked half of the population. 
Arguing that variability in ovarian hormones confounds empirical findings, girls and women 
have been excluded from research for decades. But times are changing. This review 
summarizes historical trends that have led to a knowledge gap in the role of ovarian 
hormones in neuroscience, synthesizes recent findings on ovarian hormone contributions to 
cognitive brain structures and function, and highlights areas ripe for future work. This is 
accomplished by reviewing research that has leveraged natural experiments in humans across 
the lifespan that focus on puberty, the menstrual cycle, hormonal contraceptive use, 
menopause, and menopausal hormone therapy. Although findings must be considered in light 
of study designs (e.g., sample characteristics and group comparisons versus randomized 
crossover trials), across natural experiments there is consistent evidence for associations of 
estradiol with cortical thickness, especially in frontal regions, and hippocampal volumes, as 
well as with frontal regions, during cognitive processing. There are also emerging 
investigations of resting state connectivity and progesterone along with exciting opportunities 
for future work, particularly concerning biopsychosocial moderators of and individual 
differences in effects in novel natural experiments. Thus, delineating complex ovarian 
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Introduction 
From the molecular mechanisms subserving perception to the neural networks 
underlying verbal memory, cognitive neuroscience research has transformed understanding of 
the brain. Unfortunately, the extent to which research findings generalize to female animals 
and humans is unclear because they have been excluded from research for decades, with 
scientists arguing—despite sound evidence to the contrary—that hormone variations 
confound empirical work
1, 2
. Recent research, however, has begun to explicate the noteworthy 
role of human ovarian hormones in cognitive neuroscience, revealing that women are not 
intrinsically more variable than men and that sex hormones are not confounds, but rather, 
paramount to the neural anatomy and psychophysiology of all individuals. 
  
Ovarian hormones in cognitive neuroscience: a timely investigation 
There are several reasons for the paradigm shift. First, there is ever-mounting 
evidence for sex differences in the human brain coming from systematic reviews, meta-
analyses, and journal special issues
3-6
. Differences span overall volume, regional 
morphology, trajectories of development, localized function, and patterns of connectivity. 
Second, there are indications that some neuroscientific findings in one sex do not generalize 
to the other. One example concerns the active ingredient in common sleep aids (zolpidem), 
which metabolizes differently in men and women, and, thus, impacts next-morning cognitive 
function differentially in the sexes. Because sex differences in biological responses to 
zolpidem were not initially investigated, women were given doses based on weight 
distributions in men and were at risk (e.g., for morning motor vehicle accidents) until dosage 
guidelines were modified
7
. Third, the 1993 National Institutes of Health Revitalization Act 
requires the inclusion of women and the examination of sex differences in clinical research; 








. The study of ovarian hormone contributions to cognitive neuroscience naturally 
stems from sex differences research, as hormones are plausible antecedents and correlates of 
the differences. 
 
Ovarian hormones and natural experiments 
The primary hormones secreted by the ovaries are estradiol and progesterone; the 
former is a type of estrogen and the latter a type of progestagen. Both pass through the blood–
brain barrier and have receptors throughout the brain
10
. Specifically, estradiol receptors (ERα 
and ERβ) are present throughout areas of the brain involved in cognitive functions, including 
the hippocampus and various cortical structures, especially the prefrontal cortex (PFC)
11
. 
Despite animal research demonstrating the presence of progesterone receptors (PRA and 
PRB) in brain regions involved in cognition, little is known about their location in the human 
brain
10, 12
. Natural experiments, or circumstances that lead to natural variations in 
hormones,
13, 14
 and relatively recent methodological developments in neuroimaging (e.g., 
accessibility to magnetic resonance imaging, MRI), endocrinology (e.g., availability of 
estradiol salivary assays)
15
, and computation (e.g., power to analyze multimodal data sets) 
combine to facilitate investigations into the role of ovarian hormones in cognitive 
neuroscience.  
When studying ovarian hormones, it is important to consider the nature of effects. 
Broadly, sex hormone effects on the brain and behavior can be organizational or 
activational
16, 17
. Organizational effects generally concern hormone exposure during sensitive 
periods of development; they are permanent and have historically been tied to sexual 
differentiation, in that hormone-influenced brain circuits persist throughout life and are 
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in which sex hormones stimulate brain circuits (and the sex-typed behaviors they subserve) 
only when they are present. 
  
Focus of review 
The goal here is to review recent work (i.e., within the last five years) on the role of 
ovarian hormones in shaping cognitive brain structure and function by utilizing five natural 
experiments across the human lifespan: puberty, the menstrual cycle, hormonal contraceptive 
use, menopause, and menopausal hormone therapy. The experiments are depicted by black 
lines in Figure 1, showing relative changes in ovarian hormone levels over a month (see 
inset) and across years. Each natural experiment is thought to have activational effects, and 
the majority of the literature considers these. Several experiments may also have 
organizational effects (indicated by stars). Although the greatest evidence for organizational 
effects of sex hormones on the human brain comes from androgen exposure during prenatal 
development
14
, it is increasingly clear that pubertal estrogens are organizational
18, 19
, and 
emerging longitudinal data from other natural experiments provocatively suggest that ovarian 
hormones may have organizational effects at other points in women’s lives.  
The five natural experiments are considered, in turn, in what follows. First, ovarian 
hormone variations that characterize each natural experiment are described. Next, associated 
changes in cognitive performance are briefly presented for contextualization. Finally, 
cognitive neuroscience studies on brain structure and function, including connectivity, in 
relation to the variations are synthesized; because the aim of this special issue is to 
communicate recent trends in the field, work within the past five years is examined in detail, 
following a brief synthesis of early studies to convey the state of the science through 2014. 
The review closes by integrating findings across natural experiments, noting limitations and 
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Throughout the review, the emphasis is on recent cognitive neuroscience studies 
conducted in typical samples with relatively sound methodology. This focuses the scope of 
the review, minimizes potential confounding effects of patient status and related physical and 
mental symptoms, and reduces the likelihood of presenting non-replicable results; primarily 
affective or social neuroscience studies are beyond the scope of this review. 
  
Puberty 
Puberty is characterized by stark increases in the production of sex hormones, and it 
marks the beginning of transformative adolescent changes in neurocognition
20, 21
. There are 
three axes of pubertal development: growth concerns overall changes in physiology, 
adrenarche concerns the maturation of the androgen-secreting adrenal glands, and gonadarche 
concerns maturation of the estradiol- and progesterone-secreting ovaries in girls
22
. 
Gonadarche typically occurs between the ages of 10 and 18 years, and is evident in breast 
development and menarche, or the first menstrual bleeding. Adolescent ovarian hormone 
influences on cognitive brain structure and function can be revealed through studies of the 
status or timing of gonadarche. Most work concerns the activational effects of pubertal status, 
or where an individual is in the process of puberty. There is, however, emerging work on 
pubertal timing, or when a girl develops compared to her same-age peers. Pubertal timing 
may capture organizational effects. A recent hypothesis posits that the brain has declining 
sensitivity to sex hormones throughout childhood and adolescence, such that females who 
mature early have greater effective ovarian hormone exposure than those who mature late, 
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 Research on links between pubertal ovarian hormones and cognition is scant. Despite 
evidence for cognitive improvements across adolescence
24, 25
, the limited available data 
provide little indication of an association between puberty in girls (status, timing, or estradiol 
levels) and traditional domains, such as memory, verbal fluency, and spatial skills
26-28
. There 
is some theoretical and empirical evidence, however, for pubertal hormone contributions to 
the adolescent increase in risk-related decision-making
29, 30
. Unfortunately, most studies on 




Early work on puberty and neurocognition concerned pubertal status and focused on 
the role of testosterone
31, 32
. Some work on estradiol and brain structure was conducted, 
though. Findings suggested that increases in the ovarian hormone are linked to gray matter 
decreases, including in the prefrontal cortex
33
, and also to decreases in the integrity of white 
matter tracts
34
. Results, however, were mixed across studies. For instance, there was (and 
continues to be) particular interest in ovarian hormones and hippocampal structure and 
function, given estrogen’s contributions to hippocampal synaptogenesis in animals
17
, but 
pubertal estradiol has not been consistently linked to these volumes
33, 35
. The discrepancies 
are not surprising, given the small sample sizes (i.e., n < 50 girls) of early studies.  
Early work on pubertal estradiol and brain function is also limited. A study showed 
positive links with activity in monetary reward processing regions known to be sensitized 
during adolescence, such as the striatum and medial PFC, but results did not reach traditional 
levels of significance in the small sample (n = 30 girls)
31
. Social-emotional decisions are also 
sensitized during adolescence, and a study showed a positive link between estradiol and 










 Most research on puberty and neurocognition continues to focus on testosterone and 
on pubertal status in domains strongly yoked to adolescent development (e.g., reward 
processing), with little to no consideration of pubertal timing and basic cognitive functions. 
Nonetheless, recent work with ever-increasing levels of rigor suggests that ovarian hormones, 
particularly estradiol, are indeed unique contributors to neurodevelopment. 
Cognitive brain structures. There are several recent reviews on puberty and 
structural brain development
37-39
, with two providing comprehensive lists outlining relevant 
studies
37, 39
. In these reviews, advanced pubertal status is consistently implicated in the gray 
matter reductions typical of adolescent brain development, such that estradiol increases in 
girls are linked to cortical thinning and decreased gray matter densities. There is little 
empirical evidence for estradiol influences on white matter development at puberty, though, 
as testosterone appears to underlie the change
37, 39
, aligning with sex differences in white 
matter volume favoring males
3, 38
. Findings continue to be inconsistent regarding the 
hippocampus, with advanced pubertal development in girls linked to hippocampal volumes in 
one recent study
40
, but not in another
41
. Such inconsistencies can be attributed to a variety of 
methodological issues (e.g., varying sample sizes and study designs, detection of 
nonlinearities in developmental trajectories, and challenges in disentangling pubertal status 
and age during adolescence), especially given consistent links between estrogen and the 
hippocampus found in other natural experiments (reviewed below).  
There is also some emerging work on pubertal timing and cognitive brain structures 
that is consistent with an adolescent brain reorganizational hypothesis: Early timing is 








. Thus, ovarian hormones may facilitate frontal maturation, with effects 
stronger and persistent for those with early (versus late) pubertal timing.  
Cognitive brain function. Although recent reviews consider pubertal development 
and brain function during cognitive performance—and even include comprehensive lists 
detailing relevant studies—there has been little explicit focus on ovarian hormones
38, 39
. Most 
applicable research concerns estradiol’s role in reward processing. Expanding on early 
work
31
, some studies have linked increased activity in reward processing regions, such as the 
nucleus accumbens (part of the ventral striatum), to decreased risk-taking in girls
43
, 
implicating estradiol in observed sex differences in risk aversion
3, 44
. There is some 
suggestion that the neural circuits underlying reward processing differ for monetary and 
social cues, as activity in the insula was uniquely linked to social reward processing and 
estradiol levels in adolescent girls
36, 45





. Inconsistent reports are likely due to the continued use of small samples, the 
confounding of pubertal status and age in cross-sectional studies, region-specific effects that 
depend upon connectivity within striatal subregions
46
, and menstrual cycle fluctuations in 
post-menarcheal girls. Nonetheless, estradiol seems to contribute to reward processing, and 
this is expected based on the hormone’s stimulations of and interactions with dopamine
48, 49
. 
Future work with larger samples that incorporate advanced metrics of neural connectivity and 




 There is accumulating evidence suggesting that activational effects of ovarian 
hormones, particularly estradiol, contribute to frontal gray matter reductions in adolescence 
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activational effects of estradiol contribute to social processing, and very early indications that 
organizational effects of ovarian hormones may be important for frontal cortical 
development. More work on pubertal timing is needed. This will require retrospective studies 
of pubertal timing in adults, or ideally, longitudinal studies that span puberty and young 
adulthood (to test permanence of outcomes)
50, 51
. Future work investigating progesterone and 
co-occurring menstrual cycle effects on brain structure and function during puberty and 
linked to basic cognitive functions is also needed.  
 
Menstrual cycle 
The typical menstrual cycle is 28 days long, with normal variation ranging from 22 to 
35 days
52, 53
. Menstruation is generally considered the beginning of the cycle, which is 
divided into two phases – follicular and luteal – that are defined by estradiol and progesterone 
levels. The follicular phase begins after the first day of menstruation and is characterized by 
initial low levels of both estradiol and progesterone followed by rising estradiol. The late 
follicular phase (i.e., the second week of the menstrual cycle) is characterized by rapid 
increases in estradiol that surge to a peak and trigger the release of luteinizing hormone (LH). 
Ovulation occurs shortly after the peak of estradiol and subsequent release of LH (~1 day 
after both)
54
. The luteal phase begins after ovulation and is characterized by a sharp decrease 
in estradiol that settles at moderate levels while progesterone begins to rise and reaches its 
peak approximately midway through the phase. The latter part of the luteal phase sees both 
estradiol and progesterone decline as menstruation approaches (i.e., pre-menstrual phase) and 
the cycle begins again. The focus here is on naturally cycling healthy participants, which 
provides the clearest test of activational effects, as patient studies can be confounded by 
disease processes and medication. Figure 2 presents empirically-informed simulated data 
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Notice that each woman is different with respect to the length of her cycle and her patterns of 
hormone fluctuations across phases.  
 
Cognitive performance  
A recent critical review of the literature suggests there are few replicable differences 
in cognition across the menstrual cycle or as a function of ovarian hormones
10
. Based on 
research and theory regarding sex differences in spatial and verbal abilities, however, there 




 abilities are enhanced 
when hormones are low (i.e., early follicular phase), whereas verbal and related memory 
abilities are enhanced when hormones are high (i.e., late follicular, mid-luteal phase)
57, 58
. 
Extant work is limited, however, by low power and variability in definitions of menstrual 
cycle phases. Nonetheless, consistent with the review
10
, neuroimaging studies provide 
evidence for menstrual cycle and hormone effects on neural structures and function 
underlying cognition, especially verbal abilities. It may be that neural measures are more 
sensitive to the subtle effects of hormonal milieu than is behavioral output, or that brain 
structure and function compensate for ovarian hormone variations.  
Early findings 
Early studies of menstrual cycle effects on cognitive brain structures and function are 
informative, but limited by small heterogeneous samples (e.g., including patients with 
premenstrual dysphoric disorder)
59
 and differences in when scans were performed during the 
cycle. Nonetheless, the late follicular phase (i.e., high estradiol) has been associated with 
relatively larger hippocampi as well as relatively smaller basal ganglia and anterior cingulate 
cortices (ACC)
59, 60
, with the hippocampi and basal ganglia playing a role in memory and the 
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There were also early functional studies of menstrual cycle effects on cognitive 
processes. Studies are heterogeneous and effects are mixed; however, there seems to be a 
consistent effect of estradiol levels in the frontal cortex across a variety of verbal memory 
and fluency tasks
62-65
, with some evidence that progesterone is also involved
64
. Interestingly, 
neural findings were generally not related to cognitive performance. In a particularly 
sophisticated early study, however, there was evidence for the modulation of verbal working 
memory and dorsolateral PFC activity by a combination of estradiol and the catechol-O-
methyltransferase (COMT) genotype—related to dopamine release—consistent with a role 
for estradiol in frontal cortex–mediated verbal memory functions
57
. Finally, despite several 
investigations, there is little consensus stemming from early studies on menstrual cycle 
effects on spatial abilities
63, 66, 67
: Neural processes do seem to be modulated by the menstrual 
cycle in temporal, parietal, and frontal regions, but methodological limitations challenge the 
identification of converging conclusions. 
Recent findings 
Recent findings are also limited in number and methodologically heterogeneous; 
however, they point to menstrual cycle changes in a number of brain regions, with a 
particular focus on the hippocampus
68
. Key studies from the past five years are summarized 
in Table 1.  
Cognitive brain structures. The hippocampus is implicated in a number of important 
memory functions
69
. Two recent studies reported increased hippocampal volumes during the 
late follicular phase when estradiol levels are rising and progesterone is low
70, 71
. One 
demonstrated a direct positive association between estradiol levels and hippocampal 
volumes
71








. Although these regions are close in proximity, they are 
distinguishable with regard to location and function
72
. An intensive longitudinal single-




The basal ganglia have also been of interest because they are involved in related, yet 
distinct, memory and learning mechanisms tied to the hippocampus
74
. Again, there is limited 
evidence for menstrual cycle effects; however, a recent study found that basal ganglia 
volumes are smaller when estradiol levels are relatively higher
71
, opposite the pattern 
observed for the hippocampus. In this study, participants were compared in the late follicular 
phase (when estradiol is high and progesterone is low) and the mid-luteal phase (when 
estradiol is falling but progesterone is high), but basal ganglia volumes were only positively 
correlated with progesterone levels. Together, these findings reveal the significance of 
progesterone and its interaction with estradiol.   
Finally, a number of other regions have been reported to change in size across the 
menstrual cycle and demonstrate associations with hormone levels
68
. These include the 
fusiform, other temporal regions, the medial frontal cortex, and the insula. Many are adjacent 
to those reported above and therefore might not show unique effects across the menstrual 
cycle, but rather, reflect effects on broader memory and learning circuits that could be 
revealed with future connectivity analyses.  
Cognitive brain function. A recent longitudinal study of 36 women extends earlier 
findings showing a relation between increased levels of estradiol and hippocampal function
75
. 
Interestingly, however, this relation appeared stronger in a spatial navigation than verbal 
fluency task. Moreover, there were relations between higher progesterone and greater caudate 
and dorsolateral PFC activity. These also appeared stronger during a spatial than verbal task, 
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spatial processing, recent work on menstrual cycle effects on cognitive brain functions 
concerns cognitive control and resting state functional connectivity. Regarding cognitive 
control, effects are mixed. One study reported greater no-go related activity in PFC regions 
during the late follicular compared to the late luteal/pre-menstrual phase, suggestive of a 
relation between higher estradiol and performance monitoring PFC activity, despite no links 
to behavior
76
. In direct contrast, another study found increased activity in the ACC and 
greater functional connectivity within the fronto-parietal attention network across go and no-
go trials during the menstrual/early follicular (i.e., low levels of estradiol and progesterone) 
and late follicular (i.e., rising estradiol and low progesterone) phases compared to the mid-
luteal phase (i.e., moderate levels of estradiol and high levels of progesterone), but ACC 
effects were only detected after loosening the significance threshold
77
. The discrepant 
findings likely reflect the presence of small effects that are modulated by individual 
differences (e.g., in cyclicity). A particularly strong recent study reported increased ACC 
activation to negative feedback in the mid-luteal (i.e., moderate levels of estradiol and high 
levels of progesterone) compared to the late follicular (i.e., rising estradiol and low 
progesterone) phase during completion of a reinforcement learning task
78
, suggesting a 
progestagenic effect. Behavioral performance also indicated that this increase in feedback-
related ACC activation was accompanied by increased avoidance learning, again pointing to 
a role for progesterone.     
Regarding resting state functional connectivity, studies generally fail to detect effects 
of menstrual cycle phase on connectivity metrics of whole networks, such as the hallmark 
default mode network (DMN). Rather, they report changes in how networks are related to 
particular nodes, or regions, as a function of menstrual cycle phase. For instance, there is 
some suggestion that regions within the DMN appear more connected when hormones are 
low (early follicular phase)
79, 80
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connected when progesterone or both progesterone and estradiol are high (mid-luteal 
phase)
81, 82
. But this is not always the case, as greater control-related connectivity in the early 
follicular phase (i.e., low hormones) and complex patterns of correlations between estradiol 
and progesterone in several different networks, including the DMN, have been reported
79, 83
. 






Extant research on activational menstrual cycle effects on cognitive brain structures 
and function provides preliminary insights into the role of ovarian hormones in cognitive 
neuroscience. Structural work points to the hippocampus, basal ganglia, and ACC as regions 
of interest. Functional work has further produced evidence for ovarian hormone contributions 
to frontal activity during verbal processing and memory tasks. Resting-state connectivity 
studies are particularly problematic as they do not report any menstrual cycle effects on 
intrinsic connectivity of networks per se, but changes in how nodes cohere with broader 




Hormonal contraceptives consist of a synthetic progesterone (i.e., progestin), and in 
combined formulations, a synthetic estrogen. These exogenous hormones dampen the 
production of endogenous estradiol and progesterone and control ovulation, not only making 
them effective forms of birth control, but also leading to insights about the role of ovarian 
hormones in cognitive brain structures and function. Hormonal contraceptives have various 
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oral contraceptives (OCs) because they are common, and will be used by over 85% of women 
in the United States for at least five years of their life
86
. It is important to note, however, that 
OCs are heterogeneous. Most contain 21 active pills followed by 7 placebo pills (instigating 
menstruation), but some formulations have longer or shorter pill phases. OCs also vary in 
dose, and most contain ethinyl estradiol, and have progestins with different hormone 
derivatives; for instance, some pills have progestins with androgenic activity while others are 
anti-androgenic
87, 88
. Most research concerns the activational effects of OCs, although 
organizational effects are theoretically possible.  
 
Cognitive performance 
There is increasing evidence suggesting that OC use influences cognition. Verbal 
memory seems to be most consistently facilitated by all OCs
89
, whereas spatial ability is only 
enhanced in users of pills with androgenic progestins
90, 91
. There is also indication that OC 
use decreases verbal fluency
92
. Most relevant studies are cross-sectional and conducted with 
homogenous and privileged populations (e.g., White, North American college students with 
health insurance), however, and should therefore be interpreted with caution in this nascent 
stage of research. 
 
Early findings 
Early work suggested that users (compared to naturally cycling women) have larger 
PFC and ACC volumes as well as larger hippocampal, parahippocampal, fusiform, and other 
temporal regional volumes
93
. This was supported by the lone longitudinal study in this area, 
showing larger mid-frontal gyri in users of OCs compared to naturally cycling women
60
. 
Effects even extended to differences between pill phases, such that mid-frontal gyri, ACC, 








. Moreover, an early functional study of OC users compared to women in their 
menstrual/early follicular phase showed greater right superior temporal and left inferior 
frontal cortex activation during a verbal processing task
94
. Although samples are small and 
OC formulations were not reported in these studies, they tentatively suggest that exogenous 
hormones modulate hippocampal and frontal volumes and play a role in verbal 
neurocognition, consistent with menstrual cycle research.  
 
Recent findings 
Although there is limited recent work, the emerging evidence for OC effects on 
cognition and the huge number of women using OCs makes it critical to begin to understand 
neural mechanisms. Extant findings are summarized in Table 1.  
 Cognitive brain structures. Work on OC effects on cognitive brain structures speaks 
to potential androgen effects in the context of ovarian hormones. For example, in a more 
recent cross-sectional study, women using pills containing anti-androgenic progestins were 
compared to those using pills containing androgenic progestins and naturally cycling women 
during their menstrual/early follicular phase
95
. Women taking anti-androgenic pills had larger 
parahippocampal and fusiform volumes relative to naturally cycling women, potentially 
reflecting heightened estrogenic activity in these pill users. But, these results do not replicate 





 designs. In fact, women using pills with 
androgenic progestins actually demonstrated smaller middle and superior frontal gyri than 
naturally cycling women
95
. These findings mark the complexities of studying OC effects, 
which likely involve transactions among ovarian–and other sex–hormones.  
Cognitive brain function. Despite a lack of performance differences between OC 
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reported reduced fronto-parietal activation in OC users compared to women in their follicular 
phase and greater medial PFC and inferior parietal activation in OC users compared to 
women in their mid-luteal phase
87
. Results are preliminary, though, due to the small sample, 
lack of information on OC formulation, and limited contextualizing research on the neural 
correlates of number processing. 
Resting state functional connectivity studies in OC users have also produced mixed 
results, and like in menstrual cycle studies, none find changes in overall network 
connectivity. Some studies report no differences between women using OCs and naturally 
cycling women
84
, whereas others report conflicting effects. For instance, compared to 
naturally cycling women, there is indication that women using OCs have reduced 
connectivity in DMN regions
79
, but that women using androgenic OCs have greater 
connectivity in different DMN regions
82
. There is similar confusion between studies when 
comparing active versus placebo phases in the fronto-parietal network.  
 
Summary 
 Research concerning OC effects on cognitive brain structures and function is just 
emerging. Samples are small and vary in OC formulations, which often go unreported. 
Although there is some indication of exogenous estradiol and progestin modulation of frontal 
and hippocampal regions, emerging findings suggest that interactions among ovarian 
hormones and androgens may also be important. Future systematic work is needed in this 
area, including longitudinal work that distinguishes between activational and organizational 
effects of OCs. Given the widespread use of OCs, this work is feasible and carries significant 
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Menopause, or the final menstrual period, is marked by drastic reductions in estradiol 
and progesterone levels due to the cessation of ovarian function. Natural menopause typically 
occurs around age 51 when there has been no menstrual period for 12 consecutive months
96
. 
Induced menopause, which result from treatments, such as oophorectomy (i.e., removal of the 
ovaries), can occur abruptly. The focus here is on natural menopause due to possible 
confounds in clinical patients. The menopausal reduction in ovarian hormones, particularly 
estradiol, is thought to contribute to risk for cardiovascular disease and osteoporosis as well 
as to vasomotor (e.g., hot flashes) and urogenital (e.g., vaginal dryness) symptoms
97
, begging 
the question about the activational versus organizational effects of ovarian hormone decline 
at menopause.  
 
Cognitive performance 
Along with physiological symptoms, menopausal women also often report cognitive 
decrements
98
, although empirical evidence is mixed
99
. Overall, there is suggestion that 
aspects of memory, particularly verbal memory, are negatively impacted by menopause, and 
that there are decrements in processing speed, attention, and verbal fluency. Effects, if they 
indeed exist, are likely small, and perhaps time-dependent, with some reports suggesting they 
are only present for the four years surrounding menopause (i.e., peri-menopause)
96, 100
 or 
greatest after menopause (i.e., post-menopause)
101, 102
. Inconsistencies are likely due to 
sample characteristics (e.g., age-associated cognitive decline or education) and study methods 
(e.g., cognitive domains assessed and covariates) as well as unmeasured individual 
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There is not a large corpus of research on menopause that illuminates the ways in 
which ovarian hormone decline may be linked to cognitive brain structures and function. 
There was an early report of increased frontal and temporal activation during verbal tasks 
across the menopausal transition, with neural activation inversely related to estradiol 
levels
103
. Verbal decrements accompanied this functional increase, so findings suggest links 




There is, however, some recent neuroimaging research on menopause. As was the 
case for the menstrual cycle and OC use, this work has focused on the hippocampus and, 
increasingly, the PFC, given the possible verbal and executive function impairments that 
accompany menopause
99
. Key studies from the past five years are summarized in Table 2.  
Cognitive brain structures. There is emerging evidence for structural decrements 
associated with menopause, and some suggestion that they are related to declining estradiol 
levels. For instance, compared to pre-menopausal women, post-menopausal women have 
lower gray matter volumes in the supplementary motor area and other frontal (e.g., inferior 
frontal gyrus) and temporal (e.g., superior temporal gyrus) regions, and across women, 
volumes were positively correlated with estradiol
104
. Although pre- and post-menopausal 
women also differed in hippocampal volume, findings did not withstand corrections for 
age
104
. In other work, though, hippocampal volume was positively linked to verbal memory 
in post-menopausal women
105
, providing early indication that gray matter reductions not only 
reflect estradiol decline, but also have implications for cognition. Moreover, among peri- and 
post-menopausal women, a positive association has been reported between physiologically-
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or lesions thought to reflect cardiovascular insults, which increase at menopause
96, 97
. 
Cognition was not studied, but since white matter hyperintensities appear to be related to 
cognitive impairments
107, 108
, it is reasonable to hypothesize that they contribute to cognition 
in menopausal women. 
Cognitive brain function. There is also evidence for changes in brain function 
associated with the menopause during verbal tasks and the cognitive control of emotion 
processing. With respect to verbal processing, hippocampal function seems to be altered 
among pre-, peri-, and post-menopausal women, with post-menopausal women showing the 
least hippocampal activity during verbal processing and the least hippocampal deactivation 
during verbal working memory; in both cases, hippocampal activity was related to 
estradiol
109, 110
. The difference between inverse hippocampal activation and attenuated 
hippocampal deactivation can likely be explained by varying task demands and hippocampal 
connectivity. For instance, post-menopausal women had increased connectivity among the 
bilateral hippocampi during verbal processing
109
. They also exhibited increased dorsolateral 
PFC activity during verbal working memory, and only for these post-menopausal women did 
connectivity between the dorsolateral PFC and hippocampus predict task performance
110
. 
With respect to cognitive control during emotion decision making, specifically the 
identification of negatively-valenced images, there is evidence for increasing activation 
across menopause, such that post-menopausal women uniquely engaged the PFC, posterior 
cingulate, and temporoparietal junction
111
. It is interesting to note, though, that menopausal 
status did not influence activation in traditional emotion processing regions in the limbic 
system.  
Finally, there is early indication that cognitive processes reflected in resting state 
connectivity are related to ovarian hormones at menopause. For instance, in post-menopausal 
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linked to executive network connectivity, indexed by connectivity with a dorsolateral PFC 
seed region
112
. Identifying links only with subjective measures is perplexing, and all women 
were post-menopausal, so study results do not speak to the menopausal transition per se. 
Furthermore, connectivity within the DMN, including the hippocampus, was positively 
linked to physiologically-monitored hot flashes, potentially suggesting that estradiol decline 
contributes to DMN hyperactivity, which has negative consequences for psychological well-
being
113
. It is not clear, however, how this finding aligns with a growing literature on sex 
differences in DMN connectivity, in which women are consistently shown to have greater 
connectivity than men
114
. Based on this, ovarian hormones would be expected to facilitate 
connectivity, and thus, menopause to lead to reduced DMN connectivity. To resolve these 
discrepant findings, future work should use larger samples and consider the potentially 
unique role of the hippocampus within the DMN.  
 
Summary 
There is an emerging literature on menopause that suggests ways in which ovarian 
hormones, particularly estrogen declines, contribute to cognitive brain structures and 
function. There is evidence of estradiol-linked gray matter decline in the frontal lobe and of 
altered hippocampal activation during verbal tasks across the menopausal transition. There 
are also provocative findings, including menopause-associated increases in white matter 
hyperintensities and altered cognitive processing during emotion identification and in resting 
state networks. Beyond the obvious need for replication of early findings in larger samples, 
there are also significant opportunities for future investigations utilizing longitudinal methods 
(as most extant work is cross-sectional) and for the differentiation between activational and 
organization effects.  
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Menopausal hormone therapy 
Because of the side effects associated with menopause, many women use hormone 
therapy to ease the transition, creating natural experiments for the administration of 
exogenous hormones. Menopausal hormone therapy (MHT) comes in several forms; the 
focus here is on oral and transdermal administrations thought to have systemic effects, as 
other administrations (e.g., vaginal creams) are localized. Women with natural menopause 
will likely use MHT consisting of combined estrogens and progestins; estrogens can be 
estradiol or conjugated equine estrogens, and progestins vary in their hormone derivatives (as 
in hormonal contraceptives).  
MHT has a checkered history: early work conducted as part of the Women’s Health 
Initiative (WHI) randomized controlled trial initially suggested an increased risk for 
cardiovascular disease among MHT versus placebo users, so the trial was stopped early 
115
. 
There was also evidence for cognitive and neurological deficits for WHI participants using 
MHT
116
. Although it is not clear if findings depend upon characteristics of the sample (e.g., 
weight) or MHT formulation (i.e., conjugated estrogens with an antiandrogenic progestin), it 
is noteworthy that adverse outcomes involved older (above age 65), post-menopausal women. 
Beyond these risks, there is now consensus that MHT also has some benefits (e.g., alleviates 
vasomotor symptoms and helps prevent bone fractures), especially during a critical window 
of menopause
96, 97
. Specifically, peri-menopausal MHT for about five years in healthy 





Although MHT is not recommended solely to alleviate cognitive detriments possibly 
co-occurring with menopause
100
, a relatively long history of work makes clear that it 
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memory is consistently seen to be maintained or even enhanced by estradiol treatment, and 
there is indication of small, positive effects of MHT on learning and processing speed as well 
as reduced dementia and even Alzheimer’s disease risk, although debate surrounds the 
latter
97, 100, 117, 118
. Effects vary, however, with MHT type and timing, and there are individual 




Early research on MHT suggested that ovarian hormones indeed contribute to 
cognitive brain structures and function. As was the case for menopause, most work focused 
on the frontal lobe and hippocampus
119
. For structure, there were several reports of greater 
gray matter volumes in MHT users versus non-users, including in the frontal and temporal 
cortices as well as the hippocampi
120-123
, but they were inconsistent concerning comparisons 
between current and past users, effects of age, and associations with duration of MHT. There 
were also several contradictory reports for MHT effects on the same exact regions
124-126
; the 
reports with positive effects were limited by small sample sizes and employed relatively 
young samples (post-menopausal women in their 60’s), whereas reports of volume 
decrements linked to MHT employed larger, older samples (in their 70’s). In fact, one report 
was based on the Women’s Health Initiative Memory Study (WHIMS-MRI)—an ancillary to 
the WHI study; thus, it was large (n = 1403), but participants were heterogeneous in MHT 
formulation (with some using estrogen only and others using combined estrogen + 
progesterone therapies) and of advanced age (71–89 years), with scanning conducted years 
after MHT ended. Thus, some forms of MHT likely have small effects on frontal and 
hippocampal volumes depending upon age, duration, and time since cessation of treatment. 
For function, early reports generally converged across study designs (e.g., user versus 
non-user comparisons, clinical trials, and repeated measures investigations). Utilizing 
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in MHT users versus non-users
127
, particularly in the frontal lobe and hippocampus during 
memory tasks
128
. Aligning with this, evidence from functional magnetic resonance imaging 
(fMRI) studies showed greater activation in frontal and parietal cortices as well as the 
hippocampi (among other regions) during spatial, visual, and verbal working memory 
tasks
129-133
. Interestingly, however, the increased activation associated with MHT has not 
consistently been related to working memory, as several studies reported no task performance 





Likely due to the consistency of past work on MHT and working memory-related 
neural activation, most recent cognitive neuroscience research has focused on clarifying the 
inconsistent effects of MHT on cognitive brain structures, and on extending effects of brain 
function to domains beyond memory and to ovarian hormone mechanisms. Extant studies are 
summarized in Table 2.  
Cognitive brain structures. There are recent reports of decreased frontal gray matter 
in MHT users versus non-users
134-136
, and several studies have focused on the hippocampus, 
with one showing a positive short-term (i.e., 3-month) treatment effect of relatively high 
doses of estradiol compared to low doses and placebo
137
, but two others reporting null effects 
when comparing current, past, and non-users
105, 134
. The pattern of findings could reflect 
MHT formulation (e.g., studies reporting null effects grouped users of estrogen and combined 
therapies), or neural plasticity occurring around the MHT transition. Congruent with the 
latter, follow-up data from the longitudinal WHIMS-MRI (with scanning occurring several 
years after MHT cessation) suggested reduced hippocampal volumes in MHT versus placebo 
users
135
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There are also conflicting reports of enlarged ventricular volumes, reflecting brain 
aging and cognitive decline
138
, and increased white matter hyperintensities in MHT, with 
some studies finding effects
139
, and others not
135, 136
. Again, discrepancies may be due to 
transitional versus persisting effects of MHT, as studies reporting null results were based on 
longitudinal WHIMS-MRI data collected several years after MHT cessation, and a key study 
reporting effects was a long-term (i.e., 48-month) randomized trial. Furthermore, a 3-year 
follow-up to this trial reported that ventricular volumes no longer differed among groups, but 
that white matter hyperintensities did
140
, suggesting that aging effects (reflected in ventricular 
volumes) equalize over time. Questions remain regarding MHT effects on white matter 
hyperintensities, perhaps indicating that effects are present but small or that they are 
moderated by risk factors, such as diabetes status
141
, individual differences in cognitive 
ability prior to MHT
135
, and estrogen receptor genotype
134
. As in early studies, there are few 
direct associations between brain structure and cognition in MHT users
139, 140
.  
Cognitive brain function. Studies on verbal processing confirm past work in finding 
increased frontal activation in MHT (grouping estrogen and combined) users versus non-
users
142
. Ovarian hormone mechanisms underlying this and previously-reported working 
memory effects have also been explored in a short-term (i.e., 90-day) randomized crossover 
trial of estradiol and progesterone treatment in peri-menopausal women
143
. As expected, 
estradiol treatment was linked to increased frontal activation during verbal processing. Novel 
links for progesterone were also revealed, such that it was inversely associated with frontal 
activation during verbal processing, but with increased frontal and hippocampal activation 
during working memory, potentially suggesting that previous findings of MHT treatment on 
increased neural activation
130, 133
 were not due to estradiol alone, but due to progesterone or 
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Other recent studies have considered brain activity during cognitive control and 
reward processing using cross-over designs in which the same peri- or early post-menopausal 
women participated in MHT and placebo conditions. Although intriguing and strengthened 
by the use of repeated testing, results require replication, as samples were small (n < 15). 
During a cognitive control task, combined MHT was associated with greater frontal 
activation, particularly in the PFC and ACC
144
. The increased activation did not reflect 
performance differences between study conditions, though. During a reward processing task 
in the same sample, MHT was also associated with greater putamen and ventromedial PFC 
activation, with estradiol levels during MHT positively linked to putamen activity
145
. These 
results complement those seen during puberty, with ovarian hormone increases linked to 
striatal and ventromedial PFC activation
31






There is a relatively large literature on MHT effects on cognitive brain structures and 
function. Current research suggests that peri-menopausal MHT may positively contribute to 
cognition. Unfortunately, most neuroimaging research is misaligned with this because it 
utilizes data from post-menopausal women or short-term placebo-controlled trials. Thus, 
more work with peri-menopausal samples is needed. Nonetheless, the extant literature has 
focused on MHT effects on the frontal lobes and hippocampi. Functional studies are quite 
consistent in showing that MHT increases activation in these regions during verbal and 
working memory tasks, with intriguing evidence that progesterone (along with estrogen, 
which has been the emphasis) contributes to relations, and that effects are modulated by 
individual differences. Structural studies are more mixed. Some effects (e.g., ventricular 
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whereas others (e.g., reduced frontal volume) are arguably organizational (i.e., persist after 
MHT has ended).  
 
Integration 
Across natural experiments—puberty, the menstrual cycle, hormonal contraceptives, 
menopause, and MHT—there is evidence for ovarian hormone contributions to women’s 
brain structure and function. Some effects appear to be consistent across experiments. For 
instance, estrogen plays a role in frontal and hippocampal gray matter volumes, estrogen and 
progesterone influence fluctuations in the PFC and ACC during cognitive tasks, and there is a 
unique role for estrogen in reward processing. These findings likely reflect general 
mechanisms, properties, or actions of the hormones that are expected to generalize broadly, 
including to men. Other effects emerge in some natural experiments, but not others. For 
instance, estradiol is inversely related to cortical thickness in puberty, but positively related to 
frontal gray matter in the other natural experiments, and androgen interactions seems to be 
important during puberty and in OCs. These findings likely reflect hormone interactions with 
typical age-related neural processes (e.g., in adolescence or aging), differences between 
endogenous and exogenous hormones, or regional effects in the brain. 
Findings must be interpreted in light of their actual links to cognition. Several recent 
studies do not explicitly measure cognition (see Tables 1 and 2), severely restricting their 
implications for cognitive neuroscience. Among studies that consider cognition, most report 
no neuroendocrine links to performance; in other words, neural differences associated with 
ovarian hormones are not apparent behaviorally. Thus, neuroendocrine effects might reflect 
compensation or equifinality, in that there are multiple mechanisms leading to the same 
outcome
3, 146, 147
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Considerations and limitations 
Findings must also be considered in light of study designs. Some samples are small. 
This leads to concerns that reported effects actually are false positives with inflated effect 
sizes
148
. Fortunately, awareness of the perils of small samples is rising, and recent 
publications have increased power compared to early work (see several studies in Tables 1 
and 2). Moreover, neuroimaging data from large-scale studies with information on ovarian 
hormones are being collected and made publicly available, facilitating future rigorous 




Sample characteristics are also vital to consider when evaluating studies linking 
ovarian hormones to cognitive brain structures and function. Pubertal status and timing are 
often confounded during adolescence. Measurement is paramount in menstrual cycle studies; 
self reports are inaccurate and even hormone monitoring must be done across several cycles 
to ensure precision. OC formulations (e.g., progestin androgenicity) and length of use matter; 
ignoring either can bias results. Age must be carefully considered in menopause research; it 
can reflect typical cognitive decline. Hormone constituents (e.g., conjugated equine estrogens 
or estradiol with or without a progestagen) and sample characteristics are important in MHT 
studies; formulations vary and wealthy, educated women tend to self-select into treatment. 
Furthermore, inferences from natural experiments of ovarian hormones are tightly 
yoked to study designs. Cross-sectional designs capture neural differences associated with 
hormone levels or milieus across groups (e.g., pre- versus post-menopausal women) or time 
(e.g., follicular versus luteal phase). Potential quadratic or threshold effects are often missed, 
which are problematic since hormone mechanisms are likely nonlinear and interactive
150-152
. 
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this is seldom reported. Longitudinal designs (with more than two measurement occasions) 
overcome some of these limitations. They capture hormone change and permit the 
examination of within-person nonlinear trends across time. Unfortunately, they are rare 
(though most common in puberty and menstrual cycle research). They require significant 
resources, and given the nascent stage of the field, may not provide insights for many years. 
Moreover, they provide the ability to examine both within-person changes across time and 
between-person differences across the entire study, but many extant studies fail to disentangle 
these effects, and thus, may reach inaccurate or incomplete conclusions; person-centered 
effects most directly inform hormone changes over time.  
Beyond broad distinctions of study designs, inferences are also dependent upon the 
hormone operationalizations within a given study. Different approaches can be used within a 
single natural experiment (e.g., randomized trials, comparisons of naturally occurring groups, 
and follow-up studies in MHT). Each affords different inferences, so it should not be 
surprising if effects do not converge across approaches because the hormone assessments 
reflect different neuroendocrinological processes (e.g., randomized trials reflect short-term 
transitions, while follow-up studies reflect long-term effects). Thus, it is vital for future 
studies to specify the nature of hormone influences on the brain. One way to do this is to 
consider whether ovarian hormone effects—as tested within a given study design—are 
activational or organizational. Most effects are activational, but some (e.g., those linked to the 
menstrual cycle) may be solely activational, while others are also organizational. 
Organizational effects were once thought to occur only during prenatal development
16, 17
, but 
emerging evidence that they also occur during puberty
18, 19
 begs the question of whether they 
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 It is an exciting time to study the cognitive neuroscience of ovarian hormones. The 
importance of sex differences and the hormonal mechanisms that contribute to them has been 
realized by funding agencies, convergent findings are beginning to materialize, and rigorous 
research standards are emerging. Thus, there are countless possibilities for future work. Three 
with particular promise are highlighted here.  
 
Novel natural experiments 
First, five natural experiments were considered in this review, but there are several 
others that could be used to study ovarian hormone influences on cognitive brain structures 
and function; some examples are depicted (by gray lines) in Figure 1 to highlight their 
relative hormone levels and timing during the life course. One is pregnancy, as there are huge 
changes in estrogens and progestagens during this relatively short time frame. There is meta-
analytic evidence for cognitive deficits, especially in memory and executive functioning, in 
the third trimester
153
, consistent with the speculation that ovarian hormones have nonlinear 
effects (e.g., levels that are ―too high‖ have negative sequelae). There is also evidence from 
longitudinal MRI studies: women were scanned before, immediately after, and two years post 
pregnancy, and findings revealed increasing gray matter volume reductions in frontal and 
temporal regions, including the hippocampus, with effects persisting for several years
154
. This 
is consistent with the speculation that the brain is sensitized to organizational hormone 
influences during any transitional period. Other natural experiments include precocious 
puberty (i.e., clinically early puberty, isolating effects of age and ovarian hormones)
13
, 
surgical menopause (with exaggerated effects compared to natural menopause)
155
, hormonal 
intrauterine device use (which is becoming increasingly popular)
156
, and gonadotropin-
releasing hormone agonist treatment (that allows for precise timing of ovarian hormone 
cessation)
157, 158
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intersection of natural experiments, such as pubertal adolescents who initiate OC use. Such 
samples may be challenging to study and have limitations, but this work will undoubtedly 
move cognitive neuroscience forward. 
  
Hormone interactions 
Second, most work on ovarian hormone contributions to cognitive neuroscience 
concerns estrogens, but progestagens matter, as evidenced by provocative results from 
menstrual cycle, OC, and MHT research
71, 95, 143
. Future insights will likely be facilitated by 
new prescriptions of naturally occurring P4 versus the current study of exogenous 
progestins
159
. Moreover, there are suggestive interactions between estradiol and progesterone 
during the menstrual cycle
71
 and clear indications of interactions in clinical science
152, 160
 that 
may generalize to cognitive neuroscience. Finally, both estrogen and progestagens are 
neuromodulators, and have been shown to interact with neurotransmitters, including 
dopamine, serotonin, gamma-aminobutyric acid, glutamate, and acetylcholine
10, 17, 57, 161
. 
Though challenging to study in humans, the rise of spectroscopy provides intriguing 





Third, most cognitive neuroscience research focuses on mean-level effects, assuming 
that results then apply equally to all people in a sample. Thus, there is little consideration of 
individual differences, and many studies attempt to statistically control for such variability 
(e.g., with age covariates). This could be scientifically costly. There are unmistakable 
individual differences in neuroendocrine processes (see Fig. 2), and other individual 
differences (e.g., stress, genotype, physical health, and baseline cognition) often modulate 
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effects on cognitive brain structures and function: they are person-specific, depending upon 
biology, psychology, and sociocultural experiences of individual women. Person-specific 
effects cannot be examined in traditional between-subject analyses of inter-individual 
variation (e.g., standard GLMs); instead, they require within-subject analyses of intra-
individual variation
163, 164
. Fortunately, fMRI data are well-suited to analyses of intra-
individual variation because they provide many observations from the same individual across 
time (i.e., functional volumes during a scan)
165
.  
To demonstrate the utility of a person-specific approach to research questions about 
the cognitive neuroscience of ovarian hormones, illustrative fMRI data and analyses are 
provided from a real oral contraceptive user (using a pill with 1.5 mg norethindrone acetate 
and 30 g ethinyl estradiol) scanned twice (during placebo and active phases) while 
completing a three-dimensional mental rotations task
166
 that shows a large performance 
difference favoring men and typically recruits frontal and parietal regions in women
3
. Two 
runs (each containing 16 stimuli and 134 volumes) were acquired at each scan. After standard 
preprocessing and the extraction of BOLD time series from six regions of interest shown to 
be linked to estradiol or sex differences during mental rotations performance
166, 167
, data from 
each scan were submitted to a sparse and data-driven person-specific network analysis 
approach called unified structural equation modeling (implemented within group iterative 
multiple model estimation)
168, 169
. Results are shown in Figure 3. It is clear that most 
connections present during the placebo phase (Fig. 3A) are also present in the active phase 
(Fig. 3B). Interestingly, however, there are more connections emanating from right 
hemisphere regions during the low-hormone placebo phase than the high-hormone active 
phase, consistent with the sex difference in right hemisphere lateralization favoring men
3
. 
Also, regions known to show a sex difference (e.g., right parietal)
167
 or to be linked to 
estradiol (i.e., left superior parietal)
166
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the placebo phase (blue dashed line), but not during the active phase (when both were 
contemporaneously predicted by the left inferior frontal gyrus; red solid line). Thus, brain 
regions involved in sex and ovarian hormone effects appear to be modulated by exogenous 
hormone treatment in this individual woman. Effects, however, may differ for other, unique 
women, which can be uncovered in future person-specific analyses.  
  
Conclusion 
Significant progress has been made in the understanding of ovarian hormone 
influences on cognitive brain structures and function in the past five years, ignited in part by 
calls for research on sex differences and technological advances in neuroimaging and 
biological data analysis. Particular insight has been afforded by studies of natural 
experiments, such as puberty, the menstrual cycle, hormonal contraceptive use, menopause, 
and menopausal hormone therapy. Across studies, there is compelling evidence for estradiol 
effects on the structure and function (during verbal and memory tasks) of the hippocampus 
and PFC, emerging evidence for estradiol’s interplay with dopamine during reward 
processing, and suggestion of complex interactions among sex hormones (including 
progesterone and androgen). Although inferences are limited by heterogeneity across study 
designs and samples, there is incredible opportunity for future research, especially concerning 
individual differences and biopsychosocial modulators of neuroendocrine associations in 
women, which has implications for advancing cognitive neuroscience to the benefit of all. 
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Figure 1. Depiction of natural experiments for the study of ovarian hormone influences 
across the lifespan. Relative levels across hormones (i.e., estrogens and progestagens) and 
formulations (e.g., endogenous or exogenous) are shown, as absolute levels are unknown in 
many cases. All natural experiments are thought to have activational effects on 
neurocognition, with some also having possible organizational effects (denoted with a star). 
Menstrual cycle and OC effects vary month-to-month (shown in inset), and the 
developmental timing of effects varies across individuals (denoted with fading lines).  OC: 
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Figure 2. Examples of fluctuating estradiol and progesterone across the menstrual cycle 
plotted over 35 study days. Data are simulated, but empirically informed. Ovarian hormone 
levels vary based on cycle length and individual differences in hormonal fluctuations. This 
leads to inherent differences in phase timing. (A, C, E) All phases have differential timing. 
Although the duration of late follicular/ovulation appears to be the most prominent difference 
between the plots, other phases differ in length also. (B, D, F) Though not exhaustive, several 
ways in which ovarian hormones do not follow traditionally-established patterns. Plot B 
depicts a case in which progesterone presents with an additional peak following the 
prototypical double peak during the mid-luteal phase. Plot D depicts a case in which the 
second smaller peak in estradiol during mid-luteal phase is not present, showing instead 
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Figure 3. Person-specific network models generated from unified structural equation 
modeling for an oral contraceptive user (of a pill containing ethinyl estradiol and 
norethindrone acetate) completing a three-dimensional mental rotations task during the 
placebo and active pill phases; task performance was similar across phases. Functional data 
were collected on a GE MR750 3 Tesla scanner with a 32-channel head coil using an echo-
planar imaging pulse sequence (TR = 2000 ms; TE = 25 ms; flip angle = 90˚; 64 × 64 matrix; 
3 mm
3
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T1-weighted spoiled gradient recalled acquisition structural scan (flip angle = 8˚; 256 × 256 
matrix; 1 mm
3
 voxels), and fMRI time series were extracted from brain regions of interest 
(with 6.5 mm radii at Montreal Neurologic Institute central coordinates [x, y, z]: RsupPar [52, 
-40, 58], LsupPar [-52, -40, 58], Rpar [25, -62, 42], Lpar [-25, -62, 42], RIFG [36, 20, 22], 
LIFG [-36, 20, 22]) after being intersected with the structural image (to ensure no 
incorporation of non-brain matter). All connections among brain regions are directional, with 
solid lines indicating contemporaneous relations (i.e., prediction during the same volume) and 
dashed lines indicating lagged relations (i.e., prediction from one volume to the next). Red 
lines indicate positive relations, blue lines indicate negative relations, and line thickness 
reflects relation magnitude. Autoregressive connections (i.e., lagged connections indicating 
that each region predicts itself at the next volume) were estimated for all regions. (A) The 
network during the placebo pill phase fits the data well: χ
2
(35) = 205.20, P < 0.001, RMSEA 
= 0.14, SRMR = 0.04, CFI = 0.97, NNFI = 0.94. (B) The network during the active pill phase 
also fits the data well: χ
2
(36) = 225.07, P < 0.001 , RMSEA = 0.14, SRMR = 0.04, CFI = 
0.97, NNFI = 0.94. RsupPar: right superior parietal cortex; LsupPar: left superior parietal 
cortex; Rpar: right parietal cortex; Lpar: left parietal cortex; RIFG: right inferior parietal 
gyrus; LIFG: left inferior parietal gyrus. RMSEA: root mean squared error of approximation; 




Table 1. Summary of recent cognitive neuroscience studies related to the menstrual cycle and 
hormonal contraceptives  
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OC users  


























































































































































































































































































































































































































































































































































































































Studies since 2014 included in review. Matching superscripted letters reflect data reported 
from overlapping samples. ACC; anterior cingulate cortex; DMN: default mode network; 
ECN: executive control network; FA: fractional anisotropy; FFA: fusiform face area; FPN: 
fronto-parietal network; OC: oral contraceptive; PFC: prefrontal cortex; PMDD: 
Premenstrual dysphoric disorder; PPA: parahippocampal place area; SMA: supplementary 
motor area. 
 
Table 2. Summary of recent cognitive neuroscience studies related to menopause and 
































































































































































































































































































change from 1–3 
years after 
treatment to 6–7 
years after 
treatment 
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Studies since 2014 included in table. Matching superscripted letters reflect data reported from 
overlapping samples. ACC: anterior cingulate cortex; DMN: default mode network; ECN: 
executive control network; MHT: Menopausal hormone therapy; PFC: prefrontal cortex; 
ROI: region of interest. 
 
 
